Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aztreonam-avibactam PK/PD study in sepsis patients with or without CRRT
ChiCTR2600135164Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aztreonam + avibactam in sepsis, bacterial disease, Intra-abdominal infection (IAI) and 2 more (2 arms), sponsored by Huashan Hospital. Primary endpoint: Pharmacokinetic parameters. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
aztreonam + avibactam
03
Conditions
sepsisbacterial diseaseIntra-abdominal infection (IAI)hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on ChiCTR2600135164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135164.